Anthropic’s route to public markets began quietly in June, when the Claude maker confidentially filed IPO paperwork. On Monday, it made its prospectus public and said it intends to list Class A shares on Nasdaq under the ticker ANT; the share count and price range remain undecided.¹

The filing gives the company’s own case in unusually sweeping terms. Anthropic says AI could speed scientific discovery, lift economic growth and bring cures for major diseases within reach — but insists it must pursue those gains while preventing the dangers of a revolution “this fast and this powerful.”² That framing matters: the prospectus devotes roughly 94 pages to risks, including catastrophic incidents, misuse and the prospect that insurers could be unable to cover the fallout.³

The numbers explain Wall Street’s fascination. Revenue reached $16.3 billion in the first half of 2026, up from $1.2 billion a year earlier, while operating losses narrowed to $693 million. The headline net loss was $80.7 billion, though $72.4 billion came from an accounting charge tied to convertible notes; Anthropic reported $1.6 billion in adjusted operating profit and positive operating cash flow over the same period.³

Bullish analysts argue that this is evidence frontier AI can become an operating business rather than a permanently cash-burning experiment. One analysis found second-quarter revenue rose far faster than compute spending and concluded that “Frontier-lab unit economics can turn positive at scale.”⁴

But the counterweight is immense. Anthropic has committed hundreds of billions of dollars to computing and infrastructure, while much customer revenue is usage-based and not locked into long-term contracts. Its five largest customers supplied roughly a quarter of revenue, and Amazon, Google and Microsoft are at once distributors, suppliers, investors and rivals.⁵

The governance bargain is similarly stark. Seven co-founders will retain 50.1% of voting power after the flotation, which Anthropic says protects long-term strategy and its safety mission. For public investors, the IPO is therefore not simply a growth stock purchase. It is a referendum on whether surging AI demand can finance the compute buildout — and whether a tightly controlled company can manage technology it acknowledges could carry existential risk.⁶